... After the first week, when neighbouring Germany had inoculated around 250,000 people, France was on a mere 530. By Friday, the figure had gone up to 45,500 - still so small as to be statistically meaningless.
So why has it taken so long for France to put the plan into action? It is not as if the authorities did not have time to prepare. And it is certainly not a question of a lack of vaccine. In fact, more than a million Pfizer doses are already in cold storage, waiting to be used.
The primary reason for the delay seems to be the cumbersome, over-centralised nature of France's health bureaucracy. A 45-page dossier of instructions issued by the ministry in Paris had to be read and understood by staff at old people's homes.
Each recipient then had to give informed consent in a consultation with a doctor, held no less than five days before injection. The lengthy procedure is in theory to save lives - those of patients who might have an adverse reaction. But as the critics have been arguing, delay in inoculating the population is also costing lives.
Another problem in France is the high level of scepticism towards vaccination - product of a more general suspicion of government. Polls suggest as many as 58% of the public do not want to be given the jab. The effect - critics say - has been to make the government unduly cautious. When urgency was required, the authorities were reluctant to move fast for fear of galvanising the anti-vaxxers.
